Skip to content

Exploring potential drugs for amyotrophic lateral sclerosis in Chinese medicine based on data mining and Mendelian randomisation

Exploring potential drugs for amyotrophic lateral sclerosis in Chinese medicine based on data mining and Mendelian randomisation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400088835
Enrollment
Unknown
Registered
2024-08-27
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic lateral sclerosis

Interventions

Observation group:None

Sponsors

Shaanxi Provincial Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 85 Years

Inclusion criteria

Inclusion criteria: ? Patients who meet the diagnostic standards of Western medicine and are diagnosed with ALS; ? Aged 30-85 years old; ? Complete clinical data, especially complete biochemical examination data before and after taking traditional Chinese medicine.

Exclusion criteria

Exclusion criteria: ?Cases where the diagnosis and outcome are unclear, information is missing or safety is in doubt; ?Those with incomplete medication information and clinical data; ?Patients with comorbidities such as hypertension, diabetes, and other diseases that may affect kidney function; ?Patients with a combination of acute and chronic liver and kidney function abnormalities, malignant tumours and other diseases.

Design outcomes

Primary

MeasureTime frame
Serum creatinine;

Countries

China

Contacts

Public ContactChen Jun

Shaanxi Provincial Traditional Chinese Medicine Hospital

chj2002819@163.com+86 159 9165 8129

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026